Oyster Optics, LLC v. Ciena Corporation
Filing
32
ORDER GRANTING, IN PART, AND DENYING, IN PART, 23 Motion to Dismiss. Answer due by 7/30/21. Case Management Statement due by 8/20/2021. Initial Case Management Conference set for 8/27/2021 11:00 AM in Oakland, Courtroom 5, 2nd Floor. Signed by Judge Jeffrey S. White on July 16, 2021. (jswlc3S, COURT STAFF) (Filed on 7/16/2021)
1
2
3
4
UNITED STATES DISTRICT COURT
5
NORTHERN DISTRICT OF CALIFORNIA
6
OYSTER OPTICS, LLC,
7
Plaintiff,
8
v.
9
CIENA CORPORATION,
10
Defendant.
11
United States District Court
Northern District of California
Case No. 21-cv-02241-JSW
ORDER GRANTING, IN PART, AND
DENYING, IN PART, MOTION TO
DISMISS AND SETTING INITIAL
CASE MANAGEMENT CONFERENCE
Re: Dkt. No. 23
12
Now before the Court for consideration is the motion to dismiss filed by Defendant Ciena
13
14
Corporation (“Ciena”). The Court has considered the parties’ papers, relevant legal authority, and
15
the record in this case and in the related case, Oyster Optics, LLC v. Ciena Corporation, No. 17-
16
cv-5920-JSW (“Oyster I”). The Court HEREBY GRANTS, IN PART, AND DENIES, IN PART,
17
Ciena’s motion.
BACKGROUND
18
19
This is the third lawsuit between Plaintiff Oyster Optics LLC (“Oyster”) and Ciena that is
20
pending before the undersigned.1 Oyster filed Oyster I in the United States District Court for the
21
Eastern District of Texas, and it was transferred to this Court in 2017. (See Oyster I, Dkt. Nos. 2,
22
28, 30.) In that case, Oyster initially alleged that Ciena infringed United States Patents 6,469,816
23
(the “’816 Patent”), 6,476,952 (the “’952 Patent”), 6,594,055 (the “’055 Patent”), and 7,620,327
24
(the “’327 Patent”), among others. (See generally Oyster I, Dkt. No. 2, Complaint.) Oyster filed
25
an amended complaint on March 7, 2017. (See Oyster Optics, LLC v. Coriant America, E.D. Tex.
26
27
28
1
Oyster filed the second case in this District on April 7, 2020, Oyster Optics LLC v. Ciena
Corporation, No. 20-cv-2354-JSW. It is stayed and is not relevant to the pending motion.
1
No. 16-cv-1302-JRG, Dkt. No. 35 (Oyster I Amended Complaint).)2
With respect to the ’816, ’952, and ’055 Patents, Oyster alleged that Ciena’s infringing
2
3
products included, without limitation, its FlexSelect 40G Shelf products, CoreSteam Agility, CN
4
4200 platforms, and its 6500 Series products, which are referred to as 40G products. (Oyster I
5
Complaint ¶¶ 17, 31-32, 42-43; Oyster I Amended Complaint, ¶¶ 17, 32-33, 44-45.) Oyster
6
alleged that “Ciena’s 6500 family of products, including without limitation the 6500 T-12, 6500-
7
D2, 6500-7, and 6500-S32” infringed the ’327 Patent and referred to “the exemplary infringing
8
products as the ‘100G Accused Instrumentalities.’” (Oyster I, Amended Complaint ¶ 67; see also
9
id. ¶¶ 68-74 (describing the 100G Accused Instrumentalities).)
On April 3, 2017, Oyster served infringement contentions and accused “[a]ll versions and
11
United States District Court
Northern District of California
10
variations of any product utilizing Ciena’s 6500 series products … [and] Ciena’s 4200 products”
12
of infringing the ’327 Patent. (Dkt. No. 23-1, Declaration of Blair M. Jacobs, ¶ 1, Ex. 1; see also
13
Oyster 1, Compl. ¶ 64.)
On May 19, 2017, Oyster voluntarily dismissed, without prejudice, its claims relating to
14
15
the ’816, ’952, and ’055 Patents, i.e. the patents that allegedly covered Ciena’s 40G products. On
16
January 29, 2018, the Court granted a motion to stay Oyster I pending inter partes review. (Dkt.
17
No. 59.) The stay was lifted on September 23, 2019. (Oyster I, Dkt. No. 84.) On December 13,
18
2019, Magistrate Judge Beeler was assigned to handle any discovery disputes between the parties.
19
(Id., Dkt. Nos. 90-91.)
On February 19, 2021, the parties submitted a joint letter brief relating to a dispute about
20
21
whether Ciena should be required to produce financial information regarding its 40G products.
22
(Id., Dkt. No. 156, Joint Letter Brief.) Oyster took the position that its infringement contentions
23
“prove that the accused ‘40G’ products fall well within the scope of this case.” (Joint Letter Brief
24
at 1; see also id. at 2-3.) Ciena took the position it was not required to produce that information
25
because Oyster voluntarily dismissed claims relating to the patents that covered those products.
26
(Id. at 3-5.)
27
28
2
The amended complaint was not filed in the docket in this Court when the case was
transferred.
2
On February 27, 2021, Judge Beeler issued an Order denying Oyster’s request for
1
2
discovery on the 40G products (the “Discovery Order”). (Oyster I, Dkt. No. 161.) In reaching
3
that decision, Judge Beeler stated:
4
Oyster … contends that its infringement contentions (under the
Eastern District of Texas’s patent local rule 3-1) identify 40G
products sufficiently to allow discovery of the financial information
for its calculation of damages (citing in part its footnotes allegedly
identifying 40G technology and cards). Those references are to the
products’ chassis (the box that allows either 40G or 100G cards).
They do not establish that Oyster accused the 40G products. Oyster
perhaps could have amended its infringement contentions. … But
discovery is over now.
5
6
7
8
9
10
(Discovery Order at 2:7-13 (emphasis added).) Oyster neither moved for reconsideration nor
asked the undersigned to review that decision.3
On March 30, 2021, Oyster filed this lawsuit and alleges that Ciena infringes the ’816
United States District Court
Northern District of California
11
12
Patent, the ’952 Patent, and the ’055 Patent, each of which was subject to the stipulated dismissal
13
in Oyster I. It also alleges Ciena infringes the ’327 Patent. (Compl. ¶¶ 3-6, 11-34.) The
14
“Accused Products” are Ciena’s WaveLogic T2 and R2, ActiveFlex 6500 Packet-Optical
15
Platform, and ActiveSpan 4200 Advanced Services Platform.4 (Id. ¶¶ 12, 14, 18, 20, 24, 26, 30,
16
32, Exs. E-H.)
Oyster also alleges that Ciena “knowingly and intentionally induces infringement” of the
17
18
claims of the asserted patents by “actively encourage[ing] and instruct[ing] its customers and end
19
users (for example, through user manuals and online instruction materials on its website) to use
20
the Accused Products in ways that directly infringe” the asserted patents “through the customers’
21
normal and customary use of the Accused Products.” (Id. ¶¶ 13, 19, 25, 31.)
The Court will address additional facts as necessary in the analysis.
22
23
24
25
26
27
28
3
Oyster also argued that its infringement contentions were sufficient because Ciena’s 40G
and 100G products are substantially identical and Oyster asserted representative products. Judge
Beeler rejected that argument and concluded “[o]n this record, the 40G products do not operate in
the same way as the 100G products because the energy-level detection circuitry is different.” (Id.
at 3:1-5 (citing Joint Letter Brief, Exs. J-K).) For reasons discussed below, the Court concludes
those findings are not material to this dispute.
4
For each of the asserted patents in this case, Oyster alleges these products are “illustrative
examples” of infringing products.
3
ANALYSIS
1
Ciena argues the Court should dismiss all claims for induced infringement because the
2
3
allegations are not sufficient. It also argues the Court should dismiss the claim relating to the ’327
4
Patent because Oyster improperly split its claims and is attempting to collaterally attack the
5
Discovery Order.
6
A.
Applicable Legal Standard.
Ciena moves to dismiss pursuant to Federal Rule of Civil Procedure 12(b)(6). A motion to
7
8
dismiss is proper under Rule 12(b)(6) where the pleadings fail to state a claim upon which relief
9
can be granted. The Court’s “inquiry is limited to the allegations in the complaint, which are
accepted as true and construed in the light most favorable to the plaintiff.” Lazy Y Ranch Ltd. v.
11
United States District Court
Northern District of California
10
Behrens, 546 F.3d 580, 588 (9th Cir. 2008). Even under the liberal pleading standard of Federal
12
Rule of Civil Procedure 8(a)(2), “a plaintiff’s obligation to provide the ‘grounds’ of his
13
‘entitle[ment] to relief’ requires more than labels and conclusions, and a formulaic recitation of the
14
elements of a cause of action will not do.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555 (2007)
15
(citing Papasan v. Allain, 478 U.S. 265, 286 (1986)).
Pursuant to Twombly, a plaintiff must not merely allege conduct that is conceivable but
16
17
must instead allege “enough facts to state a claim to relief that is plausible on its face.” Id. at 570.
18
“A claim has facial plausibility when the plaintiff pleads factual content that allows the court to
19
draw the reasonable inference that the defendant is liable for the misconduct alleged.” Ashcroft v.
20
Iqbal, 556 U.S. 662, 678 (2009) (citing Twombly, 550 U.S. at 556).
21
B.
22
Oyster’s Allegations of Induced Infringement Are Sufficient.
In order to state a claim for induced infringement, Oyster “must plead facts plausibly
23
showing that [Ciena] specifically intended another party to infringe the patent and knew that the
24
other party’s acts constituted infringement.” Nalco Co. v. Chem-Mod, LLC, 883 F.3d 1337, 1355
25
(Fed. Cir. 2018) (internal quotations and brackets omitted); see also 5 U.S.C. § 271(b) (“Whoever
26
actively induces infringement of a patent shall be liable as an infringer.”). Ciena does not dispute
27
that once Oyster filed suit in Oyster I it became aware of the asserted patents.
28
Ciena does argue that the facts contained in paragraphs 13, 19, 25, and 31 of the Complaint
4
1
are not sufficient to allege the remaining elements. First, it argues that the allegations that it
2
knowingly and encourages infringement by providing customers with “user manuals and online
3
instruction materials on its website” are too conclusory to state a claim. The Court is not
4
persuaded by this argument, and it finds those allegations are sufficient under Twombly. See, e.g.,
5
Teradata US, Inc. v. SAP, SE, No. 20-cv-06127-WHO, 2021 WL 326930, at *7 (N.D. Cal. Feb. 1,
6
2021); Illumina, Inc. v. BGI Genomics, Co., No. 19-cv-03770-WHO, 2020 WL 571030, at *6
7
(N.D. Cal. Feb. 5, 2020) (addressing allegations in the defendant’s counterclaims and citing
8
cases); J&K IP Assets, LLP v. Armaspec, Inc., No. 17-cv-07308-WHO, 2018 WL 2047536, at *2
9
(N.D. Cal. May 2, 2018).
Ciena also argues that Oyster fails to adequately allege it knew others were directly
10
United States District Court
Northern District of California
11
infringing the asserted patents or that it had the requisite intent. It bases these arguments on the
12
parties’ dismissal and on its efforts to defend Oyster I. However, the “undisputed facts” on which
13
Ciena relies are arguments alone. For example, the stipulated dismissal does not include any
14
information about why Oyster agreed to drop those claims. Ciena’s arguments may bear fruit as
15
this case progresses, but the Court concludes the allegations are sufficient to survive this motion to
16
dismiss.
17
C.
The Court Dismisses the Claims Relating to the ’327 Patent.
Oyster alleges that Ciena’s 40G products infringe the ‘327 Patent, which also is asserted
18
19
against Ciena in Oyster I. As a result of the Discovery Order, those products are not a part of
20
Oyster I. (See also Jacobs Decl., ¶ 5, Ex. 5 (parties agreed that 40G products need not be
21
addressed in Ciena’s expert reports).) Ciena argues Oyster has improperly split its claims.5
“It is well established that a party may not split a cause of action into separate grounds of
22
23
recovery and raise the separate grounds in successive lawsuits; instead, a party must raise in a
24
single lawsuit all the grounds of recovery arising from a single transaction or series of transactions
25
that can be brought together.” Mars Inc. v. Nippon Conlux Kabushiki-Kaisha, 58 F.3d 616, 619
26
27
28
5
In light of the Court’s ruling on this issue, it does not address Ciena’s alternative argument
that the claims regarding the ’327 Patent are an impermissible collateral attack on the Discovery
Order.
5
1
(Fed. Cir. 1995); see also Icon-IP Pty Ltd. v. Specialized Bicycle Components, Inc., No. 13-cv-
2
03677-JST, 2013 WL 10448869, at *2-3 (N.D. Cal. Oct. 22, 2013) (noting doctrine is a
3
“subspecies” of the doctrine of claim preclusion and “prevents a party from splitting a cause of
4
action into separate grounds of recovery and raising the separate grounds in successive lawsuits”).
5
In the context of patent cases, “the claim that gives rise to preclusion ... encompass[es] only the
6
particular infringing acts ... that are accused in the first action or could have been made subject to
7
that action.” Aspex Eyewear Inc. v. Marchon Eyewear, Inc., 672 F.3d 1335, 1343 (Fed. Cir. 2012)
8
(emphasis added); accord Finjan, Inc. v. Blue Coat Systems, LLC, 230 F. Supp. 3d 1097, 1103
9
(N.D. Cal. 2017).
Unlike a traditional claim preclusion analysis, the Court assumes Oyster I is final and then
10
United States District Court
Northern District of California
11
asks if the claim in this suit would be precluded. See Adams v. Cal. Dep’t of Health Servs., 487
12
F.3d 684, 688-89 (9th Cir. 2007), overruled on other grounds by Taylor v. Sturgell, 553 U.S. 880,
13
904 (2008); Icon-IP PTY Ltd., 2013 WL 10448869, at *3. That requires the Court to answer two
14
questions. First, are the parties the same? Accumed LLC v. Stryker Corp., 525 F.3d 1319, 1323
15
(Fed. Cir. 2008) (applying Ninth Circuit law).6 They are.
Second, under Federal Circuit law, do Oyster I and this case involve the same claim for
16
17
relief? Id. (applying Federal Circuit law to this question). That requires the Court to consider if
18
Ciena has demonstrated that the patents are the same and that the accused products are essentially
19
the same. Id. at 1324; see also Senju Pharm. Co., Ltd. v. Apotex, Inc., 746 F.3d 1344, 1349 (Fed.
20
Cir. 2014). There is no dispute that Oyster alleges Ciena infringes the ’327 Patent in Oyster I and
21
in this case. “Accused devices are essentially the same where the differences between them are
22
merely colorable or unrelated to the limitations in the claim of the patent.” Id. (internal quotations
23
and citations omitted).
The Court concludes that the relevant comparison of accused products is not a comparison
24
25
of the 40G and the 100G products. Instead the Court looks only to the 40G products, and Oyster
26
27
28
6
In general, in order to determine if claim preclusion applies, the Federal Circuit applies
regional circuit law. See Brain Life, LLC v. Elekta, Inc., 746 F.3d 1045, 1052 (Fed. Cir. 2014).
6
1
does not dispute that those products are the same. Although there was a dispute about whether, in
2
Oyster I, Oyster properly alleged that those products infringed the ’327 Patent, it is undisputed that
3
they were initially a part of that case. In addition, Oyster’s expert provided a report, in which he
4
opined the 40G products infringed the ’327 Patent. (See Oyster I, Dkt. No. 177-10 (Goosen
5
Expert Report).) Because the 40G products are the same in each case, the Court concludes Ciena
6
has met its burden on the second prong of the claim splitting analysis. See, e.g., Finjan, 230 F.
7
Supp. 3d at 1103 (concluding claim splitting barred some claims where, in previous case, the
8
plaintiff accused the same “combination of products” at issue in second case even though it
9
accused those products of “infringing a patent not at issue in the present motion”). The 40G
products and the ’327 Patent “are exactly the same” as in Oyster I, and Oyster could have accused
11
United States District Court
Northern District of California
10
those products then. Under the claim-splitting doctrine, Oyster “not entitled to a second bite at
12
this apple[.]” Id.
13
14
Accordingly, the Court GRANTS Ciena’s motion to dismiss the claims against the ’327
Patent, without leave to amend.
15
CONCLUSION
16
For the foregoing reasons, the Court GRANTS, IN PART, AND DENIES, IN PART,
17
Ciena’s motion to dismiss. Ciena shall file its answer within fourteen (14) days of this Order. The
18
parties shall appear for an initial case management conference on August 27, 2021, and they shall
19
file a joint case management statement by no later August 20, 2021.
20
21
22
23
IT IS SO ORDERED.
Dated: July 16, 2021
______________________________________
JEFFREY S. WHITE
United States District Judge
24
25
26
27
28
7
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?